The treatment was approved in 2024 for chronic graft-vs-host disease after failure of at least 2 prior lines of systemic therapy in patients weighing at least 40kg. The Food and Drug Administration ...
Bayer HealthCare has announced the FDA approval of their 3000 IU (international unit) vial size of Kogenate FS (recombinant antihemophilic Factor VIII). This new vial size offers greater convenience ...
Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. Photo by Adobe Stock/HealthDay ...
On March 1, 2016, we published an article in the BMJ showing how in the US nearly $3 billion will be spent on discarded cancer drugs this year because companies package drugs in vials that contain too ...
Pill bottles Vial preparation sizes can be optimized to reduce drug wastage, reduce costs. HealthDay News — Pharmaceutical vial fill volumes can be optimized to reduce drug wastage when dosing is ...
The high prices of chemotherapy drugs and the financial burden they pose on public programs, private insurers and patients is a major source of concern. However, addressing this problem through ...
Medicare could waste up to $605 million per year on the controversial Alzheimer’s drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses ...
Current lecanemab vial sizes lead to 5.8% waste, a study suggested. An estimated $133 million to $336 million worth of lecanemab may be discarded every year. Adding a 75-mg vial could save Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results